Plinabulin: Phase Ib/II started

BeyondSpring said investigators began an open-label, U.S. Phase Ib/II trial to evaluate 3.5, 20, 30 and 40 mg IV plinabulin on days 1, 8 and 15 plus IV Opdivo nivolumab on days 1 and 15 of each 4-wee...